{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:39:57Z","timestamp":1787675997149,"version":"build-2784847793"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"CIHR Centre for REACH in HIV\/AIDS","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"CIHR Foundation Grant","award":["FDN-148476"],"award-info":[{"award-number":["FDN-148476"]}]},{"DOI":"10.13039\/501100000101","name":"Pierre Elliott Trudeau Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000101","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vanier Canada Graduate Scholarship","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0174-x","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T07:33:51Z","timestamp":1500017631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Acceptability and design preferences of supervised injection services among people who inject drugs in a mid-sized Canadian City"],"prefix":"10.1186","volume":"14","author":[{"given":"Sanjana","family":"Mitra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Rachlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayden","family":"Scheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Bardwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean B.","family":"Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"issue":"6","key":"174_CR1","first-page":"2045","volume":"53","author":"DE DeWitt","year":"1996","unstructured":"DeWitt DE, Paauw DS. Endocarditis in injection drug users. Am Fam Physician. 1996;53(6):2045\u20139.","journal-title":"Am Fam Physician"},{"key":"174_CR2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","volume":"8","author":"E Lloyd-Smith","year":"2008","unstructured":"Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T. Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study. BMC Public Health. 2008;8:405.","journal-title":"BMC Public Health"},{"issue":"9737","key":"174_CR3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0140-6736(10)60743-X","volume":"376","author":"SA Strathdee","year":"2010","unstructured":"Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268\u201384.","journal-title":"Lancet"},{"issue":"1","key":"174_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jurban\/jth083","volume":"81","author":"D Vlahov","year":"2004","unstructured":"Vlahov D, Fuller C, Ompad D, Galea S, Des JD. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14\u20139.","journal-title":"J Urban Health"},{"issue":"1","key":"174_CR5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2105\/AJPH.91.1.46","volume":"91","author":"J Lorvick","year":"2001","unstructured":"Lorvick J, Kral AH, Seal K, Gee L, Edlin BR. Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. Am J Public Health. 2001;91(1):46\u20137.","journal-title":"Am J Public Health"},{"issue":"1","key":"174_CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.drugalcdep.2006.07.009","volume":"87","author":"T Kerr","year":"2007","unstructured":"Kerr T, Fairbairn N, Tyndall M, Marsh D, Li K, Montaner J, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87(1):39\u201345.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"174_CR7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1503\/cmaj.1040774","volume":"171","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J. 2004;171(7):731\u20134.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"174_CR8","first-page":"415","volume":"165","author":"A Palepu","year":"2001","unstructured":"Palepu A, Tyndall MW, Leon H, Muller J, O\u2019Shaughnessy MV, Schechter MT, et al. Hospital utilization and costs in a cohort of injection drug users. Can Med Assoc J. 2001;165(4):415\u201320.","journal-title":"Can Med Assoc J"},{"issue":"3","key":"174_CR9","first-page":"130","volume":"45","author":"E Wood","year":"2003","unstructured":"Wood E, Kerr T, Spittal PM, Tyndall MW, O\u2019Shaughnessy MV, Schechter MT. The healthcare and fiscal costs of the illicit drug use epidemic: the impact of conventional drug control strategies and the impact of a comprehensive approach. BC Med J. 2003;45(3):130\u20136.","journal-title":"BC Med J"},{"issue":"11","key":"174_CR10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.080808","volume":"179","author":"AM Bayoumi","year":"2008","unstructured":"Bayoumi AM, Zaric GS. The cost-effectiveness of Vancouver\u2019s supervised injection facility. Can Med Assoc J. 2008;179(11):1143\u201351.","journal-title":"Can Med Assoc J"},{"key":"174_CR11","volume-title":"Harm reduction: evidence, impacts, and challenges","author":"D Hedrich","year":"2010","unstructured":"Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. In: Rhodes T, Hedrich D, editors. Harm reduction: evidence, impacts, and challenges. Luxembourg: European Monitoring Centre for Drug and Drug Addiction; 2010."},{"issue":"1","key":"174_CR12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugpo.2006.12.008","volume":"18","author":"T Kerr","year":"2007","unstructured":"Kerr T, Small W, Moore D, Wood E. A micro-environmental intervention to reduce the harms associated with drug-related overdose: evidence from the evaluation of Vancouver\u2019s safer injection facility. Int J Drug Policy. 2007;18(1):37\u201345.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"174_CR13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/09595230500125047","volume":"24","author":"J Kimber","year":"2005","unstructured":"Kimber J, Dolan K, Wodak A. Survey of drug consumption rooms: Service delivery and perceived public health and amenity impact. Drug Alcohol Rev. 2005;24(1):21\u20134.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"174_CR14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/002204260203200113","volume":"32","author":"RS Broadhead","year":"2002","unstructured":"Broadhead RS, Kerr TH, Grund JP, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32(1):329\u201355.","journal-title":"J Drug Issues"},{"key":"174_CR15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/713659379","volume":"19","author":"K Dolan","year":"2000","unstructured":"Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000;19:337\u201346.","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"174_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/pubmed\/fdl090","volume":"29","author":"JA Stoltz","year":"2007","unstructured":"Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, et al. Changes in injecting practices associated with the use of a medically supervised safer injection facility. J Public Health. 2007;29(1):35\u20139.","journal-title":"J Public Health"},{"issue":"9482","key":"174_CR17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","volume":"366","author":"T Kerr","year":"2005","unstructured":"Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316\u20138.","journal-title":"Lancet"},{"issue":"9775","key":"174_CR18","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429\u201337.","journal-title":"Lancet"},{"issue":"6","key":"174_CR19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"E Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102(6):916\u20139.","journal-title":"Addiction"},{"issue":"23","key":"174_CR20","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1056\/NEJMc052939","volume":"354","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Zhang R, Stoltz JA, Lai C, Montaner JS, et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med. 2006;354(23):2512\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"174_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2006.11.010","volume":"18","author":"AM Salmon","year":"2007","unstructured":"Salmon AM, Thein R, Kimber J, Kaldor J, Maher L. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy. 2007;18(1):46\u201353.","journal-title":"Int J Drug Policy"},{"issue":"4","key":"174_CR22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","volume":"105","author":"AM Salmon","year":"2010","unstructured":"Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction. 2010;105(4):676\u201383.","journal-title":"Addiction"},{"issue":"1-2","key":"174_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.02.009","volume":"110","author":"AH Kral","year":"2010","unstructured":"Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110(1-2):160\u20133.","journal-title":"Drug Alcohol Depend"},{"key":"174_CR24","unstructured":"Bayoumi, Strike C, Brandeau M, Degani N, Fischer B, Glazier R, et al. Report on the Toronto and Ottawa Supervised Consumption Assessment Study. 2012. https:\/\/www.stmichaelshospital.com\/pdf\/research\/SMH-TOSCA-report.pdf . Accessed 16 Nov 2016."},{"issue":"8","key":"174_CR25","first-page":"759","volume":"169","author":"T Kerr","year":"2003","unstructured":"Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver\u2019s Downtown Eastside. Can Med Assoc J. 2003;169(8):759\u201363.","journal-title":"Can Med Assoc J"},{"issue":"1","key":"174_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00126334-200301010-00002","volume":"32","author":"E Wood","year":"2003","unstructured":"Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, et al. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003;32(1):2\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"174_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"K DeBeck","year":"2012","unstructured":"DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38(1):55\u201362.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"174_CR28","unstructured":"Bosman J. Inside a Killer Drug Epidemic: A Look at America\u2019s Opioid Crisis. New York Times. 2017. Retrieved June 28, 2017 from: https:\/\/www.nytimes.com\/2017\/01\/06\/us\/opioid-crisis-epidemic.html?_r=0 ."},{"issue":"3","key":"174_CR29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.drugpo.2008.01.005","volume":"19","author":"DL Gustafson","year":"2008","unstructured":"Gustafson DL, Goodyear L, Keough F. When the dragon\u2019s awake: a needs assessment of people injecting drugs in a small urban centre. Int J Drug Policy. 2008;19(3):189\u201394.","journal-title":"Int J Drug Policy"},{"key":"174_CR30","volume-title":"Below the radar: An exploration of substance use in rural Ontario","author":"K Hardill","year":"2011","unstructured":"Hardill K. Below the radar: An exploration of substance use in rural Ontario. 2011."},{"issue":"1","key":"174_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.healthplace.2008.05.004","volume":"15","author":"P Draus","year":"2009","unstructured":"Draus P, Carlson RG. Down on main street: drugs and the small-town vortex. Health Place. 2009;15(1):247\u201354.","journal-title":"Health Place"},{"key":"174_CR32","unstructured":"Statistics Canada. Focus on geography series, 2011 census. 2011. Retrieved December 2, 2016, from https:\/\/www12.statcan.gc.ca\/census-recensement\/2011\/as-sa\/fogs-spg\/Facts-cma-eng.cfm?LANG=Eng&GK=CMA&GC=555 ."},{"issue":"2","key":"174_CR33","doi-asserted-by":"crossref","first-page":"E290","DOI":"10.9778\/cmajo.20160163","volume":"5","author":"A Scheim","year":"2017","unstructured":"Scheim A, Rachlis B, Bardwell G, Mitra S, Kerr T. Public drug injecting in London, Ontario: a cross sectional survey. CMAJ Open. 2017;5(2):E290\u20134.","journal-title":"CMAJ Open"},{"key":"174_CR34","volume-title":"A profile of people who inject drugs in London, Ontario: Report on the Public Health Agency of Canada I-Track Survey, Phase 3 - Middlesex-London, 2012","author":"Middlesex-London Health Unit","year":"2013","unstructured":"Middlesex-London Health Unit. A profile of people who inject drugs in London, Ontario: Report on the Public Health Agency of Canada I-Track Survey, Phase 3 - Middlesex-London, 2012. 2013. Retrieved November 16, 2016, from http:\/\/www.healthunit.com\/uploads\/public-health-agency-of-canada-i-track-survey-phase-3.pdf ."},{"key":"174_CR35","unstructured":"Middlesex-London Health Unit. Persons who inject drugs in Middlesex-London: an update. 2016. Retrieved November 16, 2016, from https:\/\/www.healthunit.com\/uploads\/2016-06-16-report-040-16.pdf ."},{"key":"174_CR36","unstructured":"Middlesex-London Health Unit. The impact of prescription and non-prescription drug use in Middlesex-London. 2014. Retrieved November 16, 2016, from https:\/\/www.healthunit.com\/uploads\/2014-05-15-report-032-14.pdf ."},{"key":"174_CR37","unstructured":"Kerr T, Scheim A, Bardwell G, Mitra S, Rachlis B, Bacon J, et al. The Ontario Integrated Supervised Feasibility Study Report: London. 2017. London. Retrieved February, 16, 2017 from http:\/\/www.ohtn.on.ca\/wp-content\/uploads\/2017\/02\/OISIS-London-Report-Online.pdf ."},{"key":"174_CR38","volume-title":"SAS Version 9.4","author":"SAS","year":"2013","unstructured":"SAS. SAS Version 9.4. Cary: SAS Institute Inc; 2013."},{"issue":"5","key":"174_CR39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1080\/09540120802385645","volume":"21","author":"A Krusi","year":"2009","unstructured":"Krusi A, Small W, Wood E, Kerr T. An integrated supervised injecting program within a care facility for HIV-positive individuals: a qualitative evaluation. AIDS Care. 2009;21(5):638\u201344.","journal-title":"AIDS Care"},{"issue":"1","key":"174_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1477-7517-1-9","volume":"1","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, et al. Methodology for evaluating Insite: Canada\u2019s first medically supervised safer injection facility for injection drug users. Harm Reduct J. 2004;1(1):9.","journal-title":"Harm Reduct J"},{"issue":"1","key":"174_CR41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jech.2007.069013","volume":"63","author":"K DeBeck","year":"2009","unstructured":"DeBeck K, Small W, Wood E, Li K, Montaner J, Kerr T. Public injecting among a cohort of injecting drug users in Vancouver, Canada. J Epidemiol Community Health. 2009;63(1):81\u20136.","journal-title":"J Epidemiol Community Health"},{"issue":"4","key":"174_CR42","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1353-8292(01)00024-7","volume":"7","author":"K Dovey","year":"2001","unstructured":"Dovey K, Fitzgerald J, Choi Y. Safety becomes danger: dilemmas of drug-use in public space. Health Place. 2001;7(4):319\u201331.","journal-title":"Health Place"},{"issue":"10","key":"174_CR43","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1360-0443.2006.01556.x","volume":"101","author":"T Rhodes","year":"2006","unstructured":"Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. Public injecting and the need for \u2018safer environment interventions\u2019 in the reduction of drug-related harm. Addiction. 2006;101(10):1384\u201393.","journal-title":"Addiction"},{"issue":"1","key":"174_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.drugpo.2006.11.019","volume":"18","author":"W Small","year":"2007","unstructured":"Small W, Rhodes T, Wood E, Kerr T. Public injection settings in Vancouver: physical environment, social context and risk. Int J Drug Policy. 2007;18(1):27\u201336.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"174_CR45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","volume":"29","author":"E Wood","year":"2005","unstructured":"Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, et al. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29(2):126\u201330.","journal-title":"Am J Prev Med"},{"key":"174_CR46","volume-title":"The best practice recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: part 2","author":"C Strike","year":"2015","unstructured":"Strike C, Watson TM, Gohil H, Miskovic M, Robinson S, Arkell C, et al. The best practice recommendations for Canadian harm reduction programs that provide service to people who use drugs and are at risk for HIV, HCV, and other harms: part 2. Toronto: Working group on Best Practice for Harm Reduction Programs in Canada; 2015."},{"key":"174_CR47","unstructured":"NIDA. Sex and Gender Differences in Substance Use. 2017.\u00a0Retrieved February 22, 2017, from: https:\/\/www.drugabuse.gov\/publications\/research-reports\/substance-use-in-women\/sex-gender-differences-in-substance-use ."},{"key":"174_CR48","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10508-015-0508-2","volume":"45","author":"T Lyons","year":"2016","unstructured":"Lyons T, Shannon K, Richardson L, Simo A, Wood E, Kerr T. Women who use drugs and have sex with women in a Canadian setting; violence, substance use, and treatment enrolment. Arch Sex Behav. 2016;45:1403\u201310.","journal-title":"Arch Sex Behav"},{"issue":"7","key":"174_CR49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1176\/ps.2009.60.7.880","volume":"60","author":"S Greenfield","year":"2009","unstructured":"Greenfield S, Grella C. Alcohol & drug abuse: what is \u201cwomen-focused\u201d treatment for substance use disorders? Psychiatr Serv. 2009;60(7):880\u20132.","journal-title":"Psychiatr Serv"},{"issue":"Suppl 1","key":"174_CR50","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.drugpo.2014.09.003","volume":"26","author":"T Azim","year":"2015","unstructured":"Azim T, Bontell I, Strathdee SA. Women, drugs and HIV. Int J Drug Policy. 2015;26(Suppl 1):S16\u201321.","journal-title":"Int J Drug Policy"},{"key":"174_CR51","volume-title":"Substance abuse treatment: addressing the specific needs of women. Treatment Improvement Protocol (TIP) Series 51. HHS Publication No. (SMA) 09-4426","author":"Treatment CfSA","year":"2009","unstructured":"Treatment CfSA. Substance abuse treatment: addressing the specific needs of women. Treatment Improvement Protocol (TIP) Series 51. HHS Publication No. (SMA) 09-4426. Rockville: Substance Abuse and Mental Health Services Administration; 2009."},{"issue":"2","key":"174_CR52","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.psc.2010.01.004","volume":"33","author":"S Greenfield","year":"2010","unstructured":"Greenfield S, Back S, Lawson K, Brady K. Substance abuse in women. Psychiatr Clin North Am. 2010;33(2):339\u201355.","journal-title":"Psychiatr Clin North Am"},{"issue":"5","key":"174_CR53","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.socscimed.2008.05.012","volume":"67","author":"N Fairbairn","year":"2008","unstructured":"Fairbairn N, Small W, Shannon K, Wood E, Kerr T. Seeking refuge from violence in street-based drug scenes: women\u2019s experiences in North America\u2019s first supervised injection facility. Soc Sci Med. 2008;67(5):817\u201323.","journal-title":"Soc Sci Med"},{"key":"174_CR54","unstructured":"Coulter E. Violence from men, as women-only supervised injection site gets busier. News 1130. 2017 June 26, 2017."},{"key":"174_CR55","volume-title":"Women-centred harm reduction","author":"N Poole","year":"2010","unstructured":"Poole N, Urquhart C, Talbot C. Women-centred harm reduction. British Columbia Centre of Excellence for Women\u2019s Health: Vancouver; 2010."},{"key":"174_CR56","unstructured":"Vancouver Coastal Health. New substance treatment services for women on the Downtown Eastside. Vancouver, BC. 2017. Retrieve February, 22, 2017 from: http:\/\/www.vch.ca\/about-us\/news\/news-releases\/new-substance-treatment-services-for-women-on-the-Downtown-Eastside ."},{"issue":"3","key":"174_CR57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","volume":"83","author":"MW Tyndall","year":"2006","unstructured":"Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, drug use patterns, and referrals made from North America\u2019s first supervised injection facility. Drug Alcohol Depend. 2006;83(3):193\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"174_CR58","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.addbeh.2006.07.013","volume":"32","author":"S Petrar","year":"2007","unstructured":"Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E. Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility. Addict Behav. 2007;32(5):1088\u201393.","journal-title":"Addict Behav"},{"key":"174_CR59","unstructured":"Bardwell G, Scheim A, Mitra S, Kerr T. Assessing support for supervised injection services among community stakeholders in London, Canada. Int J Drug Policy. In press."},{"key":"174_CR60","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Drake","year":"1998","unstructured":"Drake S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51:253\u201363.","journal-title":"Drug Alcohol Depend"},{"key":"174_CR61","volume-title":"Board of health report: supervised injection services feasibility in middlesex-London","author":"Middlesex-London Health Unit","year":"2017","unstructured":"Middlesex-London Health Unit. Board of health report: supervised injection services feasibility in middlesex-London. 2017."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0174-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T02:43:01Z","timestamp":1569811381000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0174-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0174-x","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"article-number":"46"}}